{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:09Z","timestamp":1786991169803,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":3302,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.jacc.2004.03.054","type":"journal-article","created":{"date-parts":[[2004,7,2]],"date-time":"2004-07-02T14:52:12Z","timestamp":1088779932000},"page":"72-77","source":"Crossref","is-referenced-by-count":117,"title":["Long-term retention of cardiac resynchronization therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Bradley P","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Coman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Faddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2004.03.054_BIB1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.03.054_BIB2","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.03.054_BIB3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1388-9842(03)00057-6","article-title":"Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans","volume":"5","author":"Cleland","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2004.03.054_BIB4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0735-1097(03)01042-8","article-title":"Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias","volume":"42","author":"Higgins","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.03.054_BIB5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","article-title":"Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic LV systolic dysfunction","volume":"32","author":"Dries","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.03.054_BIB6","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction. Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.054_BIB7","unstructured":"U.S. Food and Drug Administration. InSync Biventricular Pacing System Summary of Safety and Effectiveness, Medtronic. Available at: http:\/\/www.fda.gov\/cdrh\/pdf\/P010015.html. Accessed April 22, 2004."},{"key":"10.1016\/j.jacc.2004.03.054_BIB8","unstructured":"U.S. Food and Drug Administration. InSync ICD Summary of Safety and Effectiveness, Medtronic. Available at: http:\/\/www.fda.gov\/cdrh\/pdf\/P010031b.pdf. Accessed April 22, 2004."},{"key":"10.1016\/j.jacc.2004.03.054_BIB9","unstructured":"U.S. Food and Drug Administration. CONTAK CD Summary of Safety and Effectiveness, Guidant Corporation. Available at: http:\/\/www.fda.gov\/cdrh\/pdf\/P010012.html. Accessed April 22, 2004."},{"key":"10.1016\/j.jacc.2004.03.054_BIB10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(02)01932-0","article-title":"Long-term benefits of biventricular pacing in congestive heart failure","volume":"40","author":"Linde","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.03.054_BIB11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.03.054_BIB12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET)","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.03.054_BIB13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.161.2.165","article-title":"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure","volume":"161","author":"Massie","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2004.03.054_BIB14","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.03.054_BIB15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704007788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704007788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T02:51:12Z","timestamp":1549421472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704007788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0735109704007788"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2004.03.054","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}